reports
Lifecore Biomedical to Participate at DCAT Week 2026
Lifecore Biomedical to Participate at DCAT Week 2026 CHASKA, Minn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate at DCAT Week 2026. The conference will take place March 23-26, 2026, in New York City. Details regarding Lifecore’s participation are as follows: DCAT Week 2026Details: Lifecore team will host customers and prospective partners to discuss development and manufacturing solutions for existing and n...
- Jonathan Moreland
VRNS VARONIS SYSTEMS INC.
UEPS NET 1 U.E.P.S. TECHNOLOGIES INC.
TWI TITAN INTERNATIONAL INC.
SLP SIMULATIONS PLUS
SCSC SCANSOURCE INC.
PSEC PROSPECT CAPITAL CORPORATION
PAYX PAYCHEX INC.
NG. NOVAGOLD RESOURCES INC.
MOH MOLINA HEALTHCARE INC.
MMS MAXIMUS INC.
LMAT LEMAITRE VASCULAR INC.
KVHI KVH INDUSTRIES INC.
GKOS GLAUKOS CORP
CINF CINCINNATI FINANCIAL CORPORATION
BMI BADGER METER INC.
ARE ALEXANDRIA REAL ESTATE EQUITIES INC.
ARCC ARES CAPITAL CORPORATION
ASA ASA
PRU PRUDENTIAL PLC
TSI TCW STRATEGIC INCOME FUND INC.
PLBC PLUMAS BANCORP
GRF EAGLE CAPITAL GROWTH FUND INC
LW LAMB WESTON HOLDINGS INC.
HWKN HAWKINS INC.
WDFC WD-40 COMPANY
PW POWER REIT
ABT ABBOTT LABORATORIES
KKR KKR & CO. INC.
AXR AMREP
SONO SONOS
TENB TENABLE HOLDINGS
AVTR AVANTOR
CMTV INC.
AON COMMUNITY BANCORP INC. VT
BSTZ AON PLC CLASS A
AFRM BLACKROCK SCIENCE AND TECHNOLOGY TRUST II
INTA AFFIRM HOLDINGS
TMC INTAPP INC
CHRW TMC THE METALS CO INC
TBBK C.H. ROBINSON WORLDWIDE
FRST INC.
QDEL THE BANCORP
CHUC INC.
PMN PRIMIS FINANCIAL CORP
HYMC QUIDEL CORP
CING CHARLIES HLDGS INC
SPGI PROMIS NEUROSCIENCES INC.
HYCROFT MINING HOLDING CORPORATION
CINGULATE INC
MCGRAW HILL FINANCIAL INC
AMG Reports Financial and Operating Results for the Fourth Quarter and...
AMG Reports Financial and Operating Results for the Fourth Quarter and Full Year 2025 Company reports Diluted EPS of $11.21, Economic EPS of $9.48 in the fourth quarter of 2025Diluted EPS of $22.74, Economic EPS of $26.05 for the full year 2025 Net client cash inflows of approximately $29 billion in 2025, including approximately $12 billion in the fourth quarter, driven by ongoing momentum in alternative strategiesFull-year Net income (controlling interest) of $717 million, Economic net income (controlling interest) of $769 millionFull-year Economic EPS of $26.05 increased 22% year-over-ye...
AMG Expands Its Partnership with Garda Capital Partners with Increased...
AMG Expands Its Partnership with Garda Capital Partners with Increased Investment Increased investment deepens AMG’s partnership with Garda, a leading liquid alternatives manager specializing in fixed income relative value, with an excellent long-term investment track recordGarda will remain majority-owned and led by its management teamTransaction is aligned with AMG’s long-term growth strategy and further expands Company’s exposure to alternative strategies through an increased investment in an attractive, differentiated liquid alternatives manager WEST PALM BEACH, Fla., Feb. 12, 2026 (...
AMG Announces Partnership with HighBrook Investors
AMG Announces Partnership with HighBrook Investors AMG invests in HighBrook, a real estate investment manager specializing in thematic value-add opportunities in the U.S. and EuropeHighBrook to leverage AMG’s strategic capabilities to enhance its long-term success and continue to build an enduring firmPartnership further diversifies AMG’s business and expands its participation in global private markets WEST PALM BEACH, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leading independent investment management firms globally, today announced its acquisition of a minorit...
- Jonathan Moreland
Insider Sales Into Price Weakness InsiderInsights.com Daily Ratings Re...
InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
UEPS NET 1 U.E.P.S. TECHNOLOGIES INC.
NG. NOVAGOLD RESOURCES INC.
GKOS GLAUKOS CORP
BMI BADGER METER INC.
ARCC ARES CAPITAL CORPORATION
PW POWER REIT
INTA INTAPP INC
TMC TMC THE METALS CO INC
TBBK THE BANCORP
KVUE INC.
SI KENVUE INC
CING SHOULDER INNOVATIONS INC
CINGULATE INC
- David Barden
CCI 4Q25 Results and Model Update
We are updating our model for CCI (Neutral, PT $93) following its 4Q25 results that were largely ahead of our estimates and consensus. With the removal of SATS noise from reported results, 2026 AFFO per share will be heavily influenced by the timing of the Small Cells and Fiber Segment Divestiture. As we have previously mentioned, we don’t see material upside in the stock until all the heavy lifting takes place which looks to wait until mid-year.
- David Barden
Crown Castle 4Q25 Quick Take: 2026 a transition year as CCI navigates ...
CCI (Neutral, PT $93) reported 4Q25 results that were largely ahead of our estimates and consensus. Following its previous disclosure that SATS has defaulted on its tower lease agreement payments, CCI shared organic growth guidance excluding these payments. Ahead of the close of its Small Cells and Fiber Segment in 1H26, we don’t see material upside as we wait for all the heavy lifting to take place. This said, at the end of the day, CCI will be THE pure play tower company in the US when the upp...
AMG to Announce Fourth-Quarter and Full-Year Results on February 12, 2...
AMG to Announce Fourth-Quarter and Full-Year Results on February 12, 2026 Conference Call Scheduled for 8:30 a.m. Eastern Time WEST PALM BEACH, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- AMG (NYSE: AMG) will report financial and operating results for the fourth quarter and full year ended December 31, 2025 on Thursday, February 12, 2026. A conference call will be held at 8:30 a.m. Eastern time on the same day. In addition to quarterly results, the conference call may include discussion of management’s expectations of future financial and operating results. Jay C. Horgen, Chief Execut...
Crown Castle Reports Fourth Quarter and Full Year 2025 Results and Pro...
Crown Castle Reports Fourth Quarter and Full Year 2025 Results and Provides Outlook for Full Year 2026 HOUSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") today reported results for the full year ended December 31, 2025 and issued its full year 2026 outlook, as reflected in the table below. Full Year 2026 Full Year 2025(dollars in millions, except per share amounts)Current Outlook Midpoint(a)Midpoint GrowthRate Compared to Full Year 2025 Actual ActualActual Growth Rate Compared to Full Year 2024 ActualSite rental revenues(b)$3,850(5)% $4,049(5)%Net i...
Crown Castle Announces Tax Reporting Information for 2025 Distribution...
Crown Castle Announces Tax Reporting Information for 2025 Distributions HOUSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) announced today certain year-end tax reporting information for its 2025 distributions. The following table summarizes, for income tax purposes, the nature of distributions paid to holders of Crown Castle Common Stock, par value $.01 per share (“Common Stock”), presented on a per share basis, during the calendar year ended December 31, 2025. Stockholders are urged to consult with their personal tax advisors as to their specific t...
Crown Castle Announces Fourth Quarter 2025 Earnings Conference Call De...
Crown Castle Announces Fourth Quarter 2025 Earnings Conference Call Details HOUSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") plans to release its fourth quarter 2025 results on Wednesday, February 4, 2026, after the market closes. In conjunction with the release, Crown Castle has scheduled a conference call for Wednesday, February 4, 2026, at 4:30 p.m. eastern time. A listen only live audio webcast of the conference call, along with any supplemental materials, can be accessed on the Crown Castle website at . Participants may join the conference c...
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)...
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CHASKA, Minn., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on January 14, 2026, the Lifecore compensation committee approved grants under Lifecore’s Equity Inducement Plan, as amended (the “Inducement Plan”) of restricted stock unit (“RSU”) awards with respect to an aggregate 1,738 shares of its common stock and stock options for an aggregate 8,775 shares of common stock to tw...
- David Barden
Towers & interest rates, the biggest moving parts
Given recent news around future interest rate actions by the Fed, we performed a sensitivity analysis to better understand potential AFFO per share implications for each of the three major tower companies. Based on a detailed, tranche by tranche debt analysis, SBAC (Neutral, PT $212) has the largest near-term exposure given its short-term refinancing needs. CCI (Neutral, PT $93) has limited exposure given that we expect its debt reduction using proceeds from its small cells and fiber business sa...
- David Barden
SATS defaults on CCI leases - Quantifying the readthrough
CCI (Neutral, PT $93) after the close today announced that SATS has defaulted on its tower lease agreement payments. As a result, the company has terminated the agreement and will seek to recover ~$3.5Bn+ of the remaining undiscounted payments owed. CCI says this decision will have no impact on 2025 results. As a function of this announcement, we are taking SATS payments fully out of our model for 2026E. Previously, we had zeroed out SATS payments for only 2H26 and beyond. In this note, we shar...
DISH Wireless Defaults on Payment Obligations to Crown Castle
DISH Wireless Defaults on Payment Obligations to Crown Castle DISH Obligated to Pay Crown in Excess of $3.5 Billion as Crown Castle Terminates Contract HOUSTON, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") today announced that DISH Wireless (“DISH”) has defaulted on its payment obligations to Crown Castle, causing Crown Castle to terminate its wireless infrastructure agreement with DISH. Statement by Crown Castle: “Crown Castle and many other American businesses helped DISH and its parent company, EchoStar, build its wireless communications network...
- David Barden
Towers 4Q25 Estimates & Ratings Refresh
The last 3 months have seen substantial tower price dislocation catalyzed by news that SATS intends to invoke contractual clauses and stop paying the tower industry for current leases. We highlight some key industry developments impacting sentiment and preview 4Q results based on our catch-up conversations with the companies in recent weeks.
Lifecore Biomedical to be Added to Nasdaq Biotech Index
Lifecore Biomedical to be Added to Nasdaq Biotech Index CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has been notified by Nasdaq that the company’s stock is expected to be added to the Nasdaq Biotech Index (NASDAQ: NBI) as part of the annual reconstitution of the 2025 Nasdaq indexes. Lifecore’s inclusion in the Nasdaq Biotech Index will be effective prior to market open on Monday, December 22, 2025. The Nasdaq Biotechnology Index ...
Lifecore Biomedical Signs CDMO Master Services Agreement with New Larg...
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer Agreement Calls for Development Services and Tech Transfer in Preparation for Commercial Manufacturing of Injectable Pharmaceutical Product Partner’s Program Size Positions it to Become a Top Five Commercial Customer for Lifecore CHASKA, Minn., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has signed a CDMO master services agreement wit...
Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthca...
Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference CHASKA, Minn., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 44th Annual J.P. Morgan Healthcare Conference. The conference will take place January 12-15, 2026, in San Francisco, California. Details regarding Lifecore’s participation are as follows: 44th Annual J.P. Morgan Healthcare ConferenceDetails: Lifecore management, includin...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.